FDA grants emergency use authorization for Moderna and Johnson & Johnson's COVID vaccine booster shots
CBSN
The FDA on Wednesday granted emergency use authorization to booster shots from Moderna and Johnson & Johnson, clearing a key regulatory hurdle for millions of Americans looking to boost their protection against COVID-19. Adults can now also "mix and match" their booster shots, the FDA said, and do not have to get an additional dose from the same brand that first vaccinated them.
Like with Pfizer's vaccine, the FDA is authorizing a third Moderna shot for all seniors first vaccinated at least six months ago. Other adults at high risk of exposure or severe COVID-19 will also be eligible for booster shots under the FDA's decision.
Regulators are also allowing all 15 million adult recipients of Johnson & Johnson's COVID-19 vaccine to receive a second dose at least two months after they were first vaccinated, regardless of their personal risk. Ahead of the decision, the FDA's scientists had said that the highest estimates of vaccine effectiveness from the single-shot vaccine were "consistently less" than from Pfizer or Moderna.
Measles is still making headlines in 2025, prompting questions about the life-threatening disease and how to prevent it.
It is common among older adults to not consistently get a full night's rest. But there are ways to improve sleep issues.
Microsoft is pulling the plug on Skype, the pioneering Internet telecommunications and video call platform it bought nearly 14 years ago for $8.5 billion.
Measles cases popping up across the United States, including an outbreak in Texas that has led to the death of a child, are prompting questions about where exactly the illness has been detected.